المؤلفون: Alonso-Gordoa T; Hospital Universitario Ramón y Cajal, Madrid, Spain. Electronic address: talonso@salud.madrid.org., Goodman M; Atrium Health Wake Forest Baptist, Winston-Salem, USA., Vulsteke C; Integrated Cancer Center, Maria Middelares General Hospital, Ghent; Center for Oncological Research, University of Antwerp, Antwerp, Belgium., Roubaud G; Institut Bergonié, Bordeaux, France., Zhang J; H. Lee Moffitt Cancer Center & Research Institute, Tampa., Parikh M; Hematology/Oncology Clinic, UC Davis Comprehensive Cancer Center, Sacramento, USA., Piulats JM; Catalan Institute of Oncology, Barcelona, Spain., Azaro A; Oncology R&D, AstraZeneca, Cambridge., James GD; Medical Statistics Consultancy Ltd, London, UK., Cavazzina R; Oncology R&D, AstraZeneca, Cambridge., Gangl ET; BioPharma R&D, AstraZeneca, Boston., Thompson J; Oncology R&D, AstraZeneca, Cambridge., Pouliot G; Oncology R&D, AstraZeneca, Waltham., Kumar R; Oncology R&D, AstraZeneca, Gaithersburg., Sweeney C; Dana-Farber Cancer Institute, Boston, USA.

المصدر: ESMO open [ESMO Open] 2024 Jun; Vol. 9 (6), pp. 103446. Date of Electronic Publication: 2024 Jun 04.

نوع المنشور: Journal Article; Clinical Trial, Phase II; Multicenter Study

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms, Castration-Resistant*/drug therapy , Prostatic Neoplasms, Castration-Resistant*/pathology , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/pharmacology , Antibodies, Monoclonal*/therapeutic use , Antibodies, Monoclonal*/pharmacology , Antibodies, Monoclonal*/administration & dosage, Humans ; Male ; Aged ; Middle Aged ; Taxoids/therapeutic use ; Taxoids/pharmacology ; Taxoids/administration & dosage ; Aged, 80 and over ; Progression-Free Survival ; Neoplasm Metastasis

المؤلفون: McKay RR; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive, La Jolla, CA 92037, USA. Electronic address: rmckay@health.ucsd.edu., Morgans AK; Harvard Medical School, Dana-Farber Cancer Institute, 450 Brookline Ave, Dana 09-930, Boston, MA 02215, USA. Electronic address: aliciak_morgans@dfci.harvard.edu., Shore ND; Carolina Urologic Research Center, 823 82nd Parkway, Suite B, Myrtle Beach, SC 29572, USA. Electronic address: nshore@gsuro.com., Dunshee C; Urology Specialists, 2260 W. Orange Grove Road, Tucson, AZ 85741, USA. Electronic address: cdunshee@arizonauro.com., Devgan G; Pfizer Inc., 66 Hudson Blvd East, New York, NY 10001, USA. Electronic address: geeta.devgan@pfizer.com., Agarwal N; Huntsman Cancer Institute (NCI-CCC), University of Utah, 2000 Circle of Hope Drive, Suite 5726, Salt Lake City, UT 84112, USA. Electronic address: neeraj.agarwal@hci.utah.edu.

المصدر: Cancer treatment reviews [Cancer Treat Rev] 2024 May; Vol. 126, pp. 102726. Date of Electronic Publication: 2024 Mar 29.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE

مواضيع طبية MeSH: Poly(ADP-ribose) Polymerase Inhibitors*/therapeutic use , Prostatic Neoplasms, Castration-Resistant*/drug therapy , Prostatic Neoplasms, Castration-Resistant*/pathology , Prostatic Neoplasms, Castration-Resistant*/genetics , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Androgen Receptor Antagonists*/therapeutic use , Nitriles*/therapeutic use , Piperazines*/therapeutic use , Piperazines*/administration & dosage, Humans ; Male ; Phthalazines/therapeutic use ; Phenylthiohydantoin/therapeutic use ; Phenylthiohydantoin/analogs & derivatives ; United States ; Receptors, Androgen/genetics ; Benzamides/therapeutic use ; Piperidines/therapeutic use ; Indazoles/therapeutic use ; Signal Transduction/drug effects ; Recombinational DNA Repair/drug effects

المؤلفون: Chen X; Department of Urology Surgery, The First Affiliated Hospital of Chongqing Medical University. No.1, Youyi Road, Chongqing, 400016, PR China; Department of Urology Surgery, The Ninth People's Hospital of Chongqing, Chongqing, PR China., Yang G; Department of Urology Surgery, The First Affiliated Hospital of Chongqing Medical University. No.1, Youyi Road, Chongqing, 400016, PR China., Liu M; Department of Urology Surgery, The First Affiliated Hospital of Chongqing Medical University. No.1, Youyi Road, Chongqing, 400016, PR China., Quan Z; Department of Urology Surgery, The First Affiliated Hospital of Chongqing Medical University. No.1, Youyi Road, Chongqing, 400016, PR China., Wang L; College of Laboratory Medicine, Chongqing Medical University, Chongqing, PR China., Luo C; College of Laboratory Medicine, Chongqing Medical University, Chongqing, PR China., Wu X; Department of Urology Surgery, The First Affiliated Hospital of Chongqing Medical University. No.1, Youyi Road, Chongqing, 400016, PR China. Electronic address: wuxiaohou2019@163.com., Zheng Y; Department of Urology Surgery, The First Affiliated Hospital of Chongqing Medical University. No.1, Youyi Road, Chongqing, 400016, PR China. Electronic address: zhengyongbo2019@163.com.

المصدر: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2022 Jul 12; Vol. 613, pp. 53-60. Date of Electronic Publication: 2022 Apr 30.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2104 (Electronic) Linking ISSN: 0006291X NLM ISO Abbreviation: Biochem Biophys Res Commun Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols*/pharmacology , Benzamides*/administration & dosage , Benzamides*/pharmacology , Enhancer of Zeste Homolog 2 Protein*/metabolism , Lycopene*/administration & dosage , Lycopene*/pharmacology , Nitriles*/administration & dosage , Nitriles*/pharmacology , Phenylthiohydantoin*/administration & dosage , Phenylthiohydantoin*/pharmacology , Prostatic Neoplasms, Castration-Resistant*/pathology , Proto-Oncogene Proteins c-akt*/metabolism, Cell Line, Tumor ; Drug Resistance, Neoplasm ; Drug Synergism ; Humans ; Male ; Receptors, Androgen/metabolism ; Signal Transduction

المؤلفون: Xiong X; Department of Urology, Institute of Urology, Center of National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China., Qiu S; Department of Urology, Institute of Urology, Center of National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China; Center of Biomedical Big Data, West China Hospital, Sichuan University, Chengdu, China., Yi X; Department of Urology, Institute of Urology, Center of National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China., Xu H; Department of Urology, Institute of Urology, Center of National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China., Liao D; Department of Urology, Institute of Urology, Center of National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China., Lei H; Department of Urology, Institute of Urology, Center of National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China., Bai S; Department of Urology, Institute of Urology, Center of National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China., Peng G; Department of Endocrinology and Metabolism, West China Hospital of Sichuan University, Chengdu, China., Ai J; Department of Urology, Institute of Urology, Center of National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China. Electronic address: ajz6363@126.com., Yang L; Department of Urology, Institute of Urology, Center of National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China. Electronic address: wycleflue@163.com.

المصدر: Urologic oncology [Urol Oncol] 2021 Nov; Vol. 39 (11), pp. 754-763. Date of Electronic Publication: 2021 Jul 28.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 9805460 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2496 (Electronic) Linking ISSN: 10781439 NLM ISO Abbreviation: Urol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Androstenes/*therapeutic use , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Prednisone/*therapeutic use , Prostatic Neoplasms, Castration-Resistant/*drug therapy, Androstenes/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Humans ; Male ; Neoplasm Metastasis ; Prednisone/pharmacology ; Progression-Free Survival ; Prostatic Neoplasms, Castration-Resistant/mortality ; Treatment Outcome

المؤلفون: Sweeney C; Dana-Farber Cancer Institute, Boston, MA, USA., Bracarda S; Azienda Ospedaliera Santa Maria, Terni, Italy., Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York-Presbyterian, New York City, NY, USA., Chi KN; BC Cancer, Vancouver, BC, Canada., Olmos D; Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain., Sandhu S; Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC, Australia., Massard C; Institut Gustave Roussy, Villejuif, France., Matsubara N; National Cancer Center Hospital East, Chiba, Japan., Alekseev B; P A Herzen Moscow Oncology Research Institute, Moscow, Russia., Parnis F; Ashford Cancer Centre Research, Kurralta Park, SA, Australia., Atduev V; Volga District Medical Centre under Federal Medical and Biological Agency of Russia, Nizhny Novgorod, Russia., Buchschacher GL Jr; Kaiser Permanente Southern California, Los Angeles Medical Center, Los Angeles, CA, USA., Gafanov R; Russian Scientific Center of Roentgenology and Radiology, Moscow, Russia., Corrales L; Medical Oncology, Centro de Investigación y Manejo del Cáncer CIMCA, San José, Costa Rica., Borre M; Aarhus University Hospital, Aarhus, Denmark., Stroyakovskiy D; Moscow City Oncology Hospital Number 62 of Moscow Healthcare Department, Moscow Oblast, Russia., Alves GV; Centro Integrado de Pesquisa em Oncologia, Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil., Bournakis E; Oncologic Clinical Trials and Research Clinic, Metropolitan General Hospital, Athens, Greece., Puente J; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC, Madrid, Spain., Harle-Yge ML; F Hoffmann-La Roche, Basel, Switzerland., Gallo J; F Hoffmann-La Roche, Basel, Switzerland., Chen G; Genentech, South San Francisco, CA, USA., Hanover J; Genentech, South San Francisco, CA, USA., Wongchenko MJ; Genentech, South San Francisco, CA, USA., Garcia J; F Hoffmann-La Roche, Basel, Switzerland., de Bono JS; Division of Clinical Studies, The Institute of Cancer Research, London, UK; Drug Development Unit, Royal Marsden Hospital, Sutton, UK. Electronic address: johann.de-bono@icr.ac.uk.

المصدر: Lancet (London, England) [Lancet] 2021 Jul 10; Vol. 398 (10295), pp. 131-142.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

مواضيع طبية MeSH: Androstenes/*therapeutic use , Antineoplastic Agents/*therapeutic use , Antineoplastic Agents, Hormonal/*therapeutic use , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Piperazines/*therapeutic use , Prednisolone/*therapeutic use , Prostatic Neoplasms, Castration-Resistant/*drug therapy , Pyrimidines/*therapeutic use, Aged ; Double-Blind Method ; Humans ; Male ; Progression-Free Survival ; Prostatic Neoplasms, Castration-Resistant/physiopathology

المؤلفون: Li J; Department of Urology Oncological Surgery, Chongqing University Cancer Hospital, Han Yu Road 181, 400030 Chongqing, China., Dai J; Department of Urology Oncological Surgery, Chongqing University Cancer Hospital, Han Yu Road 181, 400030 Chongqing, China., Xian P; Department of Urology Oncological Surgery, Chongqing University Cancer Hospital, Han Yu Road 181, 400030 Chongqing, China., Xiong L; Department of psychology, Chongqing University Cancer Hospital, 400030 Chongqing, China., Song Y; Department of Urology Oncological Surgery, Chongqing University Cancer Hospital, Han Yu Road 181, 400030 Chongqing, China., Tang X; Department of Urology Oncological Surgery, Chongqing University Cancer Hospital, Han Yu Road 181, 400030 Chongqing, China., Li Y; Department of Urology Oncological Surgery, Chongqing University Cancer Hospital, Han Yu Road 181, 400030 Chongqing, China., Wu Y; Radiation Therapy Center, Chongqing University Cancer Hospital, Han Yu Road 181, 400030 Chongqing, China. Electronic address: cqmdwyz@163.com., Zhou H; Department of Urology Oncological Surgery, Chongqing University Cancer Hospital, Han Yu Road 181, 400030 Chongqing, China. Electronic address: berzou@163.com., Liu N; Department of Urology Oncological Surgery, Chongqing University Cancer Hospital, Han Yu Road 181, 400030 Chongqing, China. Electronic address: 1054567372@qq.com.

المصدر: Cancer treatment and research communications [Cancer Treat Res Commun] 2021; Vol. 27, pp. 100368. Date of Electronic Publication: 2021 Mar 30.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101694651 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-2942 (Electronic) Linking ISSN: 24682942 NLM ISO Abbreviation: Cancer Treat Res Commun Subsets: MEDLINE

مواضيع طبية MeSH: Radiosurgery*/adverse effects, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Prostatic Neoplasms, Castration-Resistant/*therapy, Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cystitis/etiology ; Docetaxel/administration & dosage ; Dose Fractionation, Radiation ; Follow-Up Studies ; Gonadotropin-Releasing Hormone/agonists ; Gonadotropin-Releasing Hormone/antagonists & inhibitors ; Humans ; Male ; Neoplasm Grading ; Orchiectomy ; Proctitis/etiology ; Progression-Free Survival ; Prospective Studies ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms, Castration-Resistant/blood ; Prostatic Neoplasms, Castration-Resistant/pathology ; Radiation Injuries/etiology ; Random Allocation ; Survival Rate ; Tumor Burden

المؤلفون: Batra JS; Department of Urology, Weill Cornell Medicine, New York, NY., Niaz MJ; Department of Urology, Weill Cornell Medicine, New York, NY., Whang YE; Department of Medicine, Division of Hematology/Oncology, University of North Carolina School of Medicine, Chapel Hill, NC., Sheikh A; Department of Radiology, Icahn School of Medciine at Mount Sinai, New York, NY., Thomas C; Department of Biostatistics and Epidemiology, Weill Cornell Medicine, New York, NY., Christos P; Department of Biostatistics and Epidemiology, Weill Cornell Medicine, New York, NY., Vallabhajosula S; Division of Molecular Imaging and Therapeutics, Department of Radiology, Weill Cornell Medicine, New York, NY., Jhanwar YS; Division of Molecular Imaging and Therapeutics, Department of Radiology, Weill Cornell Medicine, New York, NY., Molina AM; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY; Meyer Cancer Center, Weill Cornell Medicine, NewYork Presbyterian Hospital, New York, NY., Nanus DM; Department of Urology, Weill Cornell Medicine, New York, NY; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY; Meyer Cancer Center, Weill Cornell Medicine, NewYork Presbyterian Hospital, New York, NY., Osborne JR; Division of Molecular Imaging and Therapeutics, Department of Radiology, Weill Cornell Medicine, New York, NY; Meyer Cancer Center, Weill Cornell Medicine, NewYork Presbyterian Hospital, New York, NY., Bander NH; Department of Urology, Weill Cornell Medicine, New York, NY; Meyer Cancer Center, Weill Cornell Medicine, NewYork Presbyterian Hospital, New York, NY., Tagawa ST; Department of Urology, Weill Cornell Medicine, New York, NY; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY; Meyer Cancer Center, Weill Cornell Medicine, NewYork Presbyterian Hospital, New York, NY. Electronic address: stt2007@med.cornell.edu.

المصدر: Urologic oncology [Urol Oncol] 2020 Nov; Vol. 38 (11), pp. 848.e9-848.e16. Date of Electronic Publication: 2020 Jun 27.

نوع المنشور: Clinical Trial, Phase I; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 9805460 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2496 (Electronic) Linking ISSN: 10781439 NLM ISO Abbreviation: Urol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*administration & dosage , Antineoplastic Agents/*administration & dosage , Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Docetaxel/*administration & dosage , Prostatic Neoplasms, Castration-Resistant/*drug therapy, Aged ; Aged, 80 and over ; Humans ; Male ; Maximum Tolerated Dose ; Middle Aged ; Neoplasm Metastasis ; Prospective Studies ; Prostatic Neoplasms, Castration-Resistant/pathology

المؤلفون: George DJ; Departments of Medicine and Surgery, Duke Cancer Institute, Duke University, Durham, NC. Electronic address: daniel.george@duke.edu., Sartor O; Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA., Miller K; Charité Universitätsmedizin Berlin, Urologische Klinik und Hochschulambulanz, Berlin, Germany., Saad F; University of Montréal Hospital Centre, Montréal, Quebec, Canada., Tombal B; Division of Urology, Institute of Experimental and Clinical Research, Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium., Kalinovský J; Bayer Consumer Care AG, Basel, Switzerland., Jiao X; Bayer HealthCare Pharmaceuticals, Whippany, NJ., Tangirala K; Bayer HealthCare Pharmaceuticals, Whippany, NJ., Sternberg CN; Weill Cornell Department of Medicine, New York-Presbyterian Hospital, New York, NY., Higano CS; Department of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA.

المصدر: Clinical genitourinary cancer [Clin Genitourin Cancer] 2020 Aug; Vol. 18 (4), pp. 284-294. Date of Electronic Publication: 2020 Jan 07.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Prostatic Neoplasms, Castration-Resistant/*mortality, Aged ; Androstenes/administration & dosage ; Benzamides/administration & dosage ; Docetaxel/administration & dosage ; Follow-Up Studies ; Humans ; Male ; Nitriles/administration & dosage ; Phenylthiohydantoin/administration & dosage ; Prognosis ; Prostatic Neoplasms, Castration-Resistant/drug therapy ; Prostatic Neoplasms, Castration-Resistant/secondary ; Retrospective Studies ; Survival Rate ; Taxoids/administration & dosage ; Tissue Extracts/administration & dosage

المؤلفون: Yoshida S; Department of Urology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan. Electronic address: s-yoshida.uro@tmd.ac.jp., Takahara T; Department of Biomedical Engineering, Tokai University School of Engineering, Tokyo, Japan; AIC Yaesu Clinic, Tokyo, Japan., Ishii C; AIC Yaesu Clinic, Tokyo, Japan., Arita Y; AIC Yaesu Clinic, Tokyo, Japan; Department of Diagnostic Radiology, Keio University School of Medicine, Tokyo, Japan., Waseda Y; Department of Urology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan., Kijima T; Department of Urology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan., Yokoyama M; Department of Urology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan., Ishioka J; Department of Urology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan., Matsuoka Y; Department of Urology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan., Saito K; Department of Urology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan., Fujii Y; Department of Urology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan.

المصدر: Clinical genitourinary cancer [Clin Genitourin Cancer] 2020 Aug; Vol. 18 (4), pp. e391-e396. Date of Electronic Publication: 2019 Dec 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Data Systems*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Bone Neoplasms/*secondary , Diffusion Magnetic Resonance Imaging/*standards , Information Systems/*statistics & numerical data , Prostatic Neoplasms, Castration-Resistant/*pathology, Aged ; Aged, 80 and over ; Bone Neoplasms/drug therapy ; Diffusion Magnetic Resonance Imaging/methods ; Disease Progression ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Prognosis ; Prostatic Neoplasms, Castration-Resistant/drug therapy ; Retrospective Studies ; Survival Rate

المؤلفون: Madan RA; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Schmidt KT; Clinical Pharmacology Program, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Karzai F; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Peer CJ; Clinical Pharmacology Program, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Cordes LM; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Chau CH; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Steinberg SM; Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Owens H; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Eisner J; Innocrin Pharmaceuticals Inc, Durham, NC., Moore WR; Innocrin Pharmaceuticals Inc, Durham, NC; Vizuri Health Sciences LLC, Fairfax, VA., Dahut WL; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Gulley JL; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Figg WD; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; Clinical Pharmacology Program, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD. Electronic address: figgw@helix.nih.gov.

المصدر: Clinical genitourinary cancer [Clin Genitourin Cancer] 2020 Aug; Vol. 18 (4), pp. 258-267.e1. Date of Electronic Publication: 2020 Mar 29.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Intramural

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Drug Resistance, Neoplasm/*drug effects , Prostatic Neoplasms, Castration-Resistant/*drug therapy, Aged ; Aged, 80 and over ; Benzamides/administration & dosage ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Naphthalenes/administration & dosage ; Nitriles/administration & dosage ; Phenylthiohydantoin/administration & dosage ; Prognosis ; Prostatic Neoplasms, Castration-Resistant/pathology ; Survival Rate ; Triazoles/administration & dosage